Does Intraoperative Hetastarch Administration Increase Blood Loss and Transfusion Requirements After Cardiac Surgery?

Authors:
  • JKJill E. Knutson
    Jill E. Knutson
  • JDJane A. Deering
    Jane A. Deering
  • FHFrank W. Hall
    Frank W. Hall
  • GNGregory A. Nuttall
    Gregory A. Nuttall
  • DSDarrell R. Schroeder
    Darrell R. Schroeder
  • RWRoger D. White
    Roger D. White
  • CMCharles J. Mullany
    Charles J. Mullany

Abstract
Our large retrospective study suggests that intraoperative use of hetastarch in primary cardiac surgery with cardiopulmonary bypass may increase bleeding and transfusion requirements. A large prospective study is needed to determine if intraoperative administration of hetastarch should be avoided during cardiovascular surgery.

This publication has 23 references indexed in Scilit: